J&J's experimental psoriasis drug shows promise against Bristol's treatment

Johnson & Johnson said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's Sotyktu in two late-stage head-to-head trials. ...